Havens Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-191,000
Closed -$3M 56
2022
Q2
$3M Sell
191,000
-17,800
-9% -$272K 4.74% 8
2022
Q1
$3.18M Sell
208,800
-64,473
-24% -$982K 5.83% 5
2021
Q4
$4.2M Buy
+273,273
New +$3.6M 4.96% 8

Other funds holding NPTN

Havens Advisors's NPTN Position: Q3 2022 in Review

Havens Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 191,000 shares — an estimated $3M sold.

Havens Advisors first reported a position in NPTN in Q4 2021 and held it in 3 quarters. The position peaked at $4.2M in Q4 2021. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Havens Advisors reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Havens Advisors sold 191,000 NEOPHOTONICS CORP shares in Q3 2022, an estimated $3M.
  • Havens Advisors first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 3 quarters.
  • Havens Advisors's NEOPHOTONICS CORP position peaked at $4.2M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Havens Advisors's 13F filing for Q3 2022, filed 12 Oct 2022.